| 主題：
Topic |
Chromatin remodeling genes in gynecologic cancer progression and therapy |
| 演講者：
Speaker |
施益民 教授 Ie-Ming Shih, M.D., Ph.D.
Richard W. TeLinde Distinguished Professor
Director, TeLinde Gynecologic Disease Program
Co-Director, Women’s Malignancies Program
Johns Hopkins University School of Medicine |
| 時間：
Date |
111年2月22日(二) 上午10:00~12:00
February 22, 2022, 10:00-12:00 |
| 地點：
Venue |
醫學綜合大樓前棟四樓誠樸廳
4F Hall, Comprehensive Medical Building (Front Building) |
| 語言：
Language |
中文 Chinese |
| 主辦單位：
Organizer |
醫學科學研究所 |
Abstract:
ARID1A has emerged as a tumor suppressor gene, which is mutated in a broad spectrum of cancers, especially in those gynecologic cancers arising from ectopic or eutopic endometrium including ovarian clear cell, ovarian endometrioid and uterine endometrioid carcinomas. As a subunit of SWI/SNF chromatin remodeler, ARID1A facilitates target-specific binding of SWI/SNF complexes to chromatin, thereby altering the accessibility of chromatin to a variety of nuclear factors. In human cancer, ARID1A possesses not only features of a gatekeeper, regulating cell cycle progression, but also features of a caretaker, preventing genomic instability through DNA damage repair. Moreover, an increasing body of evidence suggests that ARID1A containing SWI/SNF complexes play a pivotal role in transcriptional regulation of genes involving in several cancer-associated signaling pathways. In this seminar, we will discuss the mechanisms underlying how ARID1A mutations cause cancer progression and the clinical implications of synthetic lethality in developing ARID1A mutation-based therapeutics.
※教職員請至「人才發展系統」報名：
請登入「人才發展系統」https://ehrd.tmu.edu.tw/eHRD/eHRDOrg → (左上方) 查詢與申請→ 課程「醫科所【拇山生物醫學研究講座】– 111/02/22 演講者：施益民 教授 (Johns Hopkins University School of Medicine)」(「關鍵字」可以搜尋：拇山 ) →教室→確認
※學生請至「學術活動網」報名：http://event.tmu.edu.tw/actnews/?Sn=4370
主講人：龍安靖 執行長 (醫守科技股份有限公司執行長兼共同創辦人)
會議資訊：
誠摯邀請：全校教職員生及相關領域同好，踴躍報名參加！
ICHIT’s FB：
